We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
PRENOXAD 1mg/mL Solution for Injection in a pre-filled syringe (naloxone hydrochloride)
Section 19A approved medicine
PRENOXAD 1mg/mL Solution for Injection in a pre-filled syringe (naloxone hydrochloride)
Section 19A approval holder
Phebra Pty Ltd ABN 99 059 357 890
Phone
02 9420 9199
Approved until
Status
Current
Indication(s)
Prenoxad Injection is intended for the complete or partial reversal of respiratory depression induced by natural and synthetic opioids. It may also be used for the diagnosis of suspected acute opioid overdose.
Additional information
Images
